GLP-1

GLP-1 refers to a class of drugs that mimic a natural hormone to regulate appetite and blood sugar, primarily used for managing type 2 diabetes and obesity.

Why it’s in the news: It is in the news due to expanding research into new applications like pain relief and its growing adoption as a lifestyle drug for weight management.

Latest on GLP-1

• We’re still figuring out the side effects of GLP-1 weight-loss drugs
• GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution
• Opinion: I studied GLP-1 use in children. The results are reassuring
• STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
• STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more
• This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Connections

12 entities linked to GLP-1 across the news graph.